| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000010020 |
| Receipt No. | R000010724 |
| Official scientific title of the study | Clinical study to investigate the efficacy of warfarin for intractable urticaria |
| Date of disclosure of the study information | 2013/02/18 |
| Last modified on | 2017/08/17 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Clinical study to investigate the efficacy of warfarin for intractable urticaria | |
| Title of the study (Brief title) | Clinical study to investigate the efficacy of warfarin for intractable urticaria | |
| Region |
|
|
| Condition | ||
| Condition | Urticaria | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the efficacy, safety, and doses of warfarin for intractable urticaria |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Symptoms and Urticarial scores before and after taking warfarin |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Warfarin | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | A) Patients who are suffuring from urticaria and are 20 years old or more and less than 70 years old.
B) Patients who are insufficiently controlled by standard therapies, or are not able to use standard medicines due to the adverse effects. C) Patients who can come to our outpatient clinic. D) Patients who can give consent in writing. |
|||
| Key exclusion criteria | A) Patiets who take medical agents that influence on coagulation system.
B) Bleeding patients. C) Patients who has the risks of bleeding. E) Patients who are recently operated or injured. F) Patients who previously had the adverse drug reaction against warfarin. And patients who can not stop taking medications which show drug interaction with warfarin. G) Patients who are pregnant or have chance of pregnancy. H) Patients who are medicated by vitamineK. I) Patiens who are pegged as unsuitable for this study by their doctor. J) Patients who has the potential of injury or contused wound by heavy exercise or work. |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Michihiro Hide |
| Organization | Hiroshima University Hospital |
| Division name | Department of Dermatology |
| Address | 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551 |
| TEL | 082-257-5237 |
| ed1h-w1de-road@hiroshima-u.ac.jp | |
| Public contact | |
| Name of contact person | Satoshi Morioke |
| Organization | Hiroshima University Hospital |
| Division name | Department of Dermatology |
| Address | 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551 |
| TEL | 082-257-5237 |
| Homepage URL | |
| morioke-hma@hiroshima-u.ac.jp | |
| Sponsor | |
| Institute | Department of Dermatology, Integrated Health Sciences, Institute of Biomedical & Health Sciences, Hiroshima University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 広島大学病院(広島県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000010724 |